Kaan Koçali | Health Professions | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Kaan Koçali, Health Professions, Best Researcher Award

Assist. Prof. Dr. Kaan Koçali, Istanbul Gelisim University, Turkey

Dr. Kaan Koçali is an esteemed academic specializing in occupational health and safety. He earned his doctorate in Occupational Health and Safety from Istanbul Aydın University in 2021. With a diverse educational background, he holds multiple degrees, including a master's in Mining Engineering and Entrepreneurship, and a bachelor's degree in various engineering fields. Dr. Koçali's academic and professional journey has been shaped by his dedication to improving workplace safety and health standards. His expertise has made a significant impact in the mining industry, through research projects and consultancy work. Currently, he serves as a lecturer at Istanbul Gelisim University, focusing on safety regulations and risk assessments. His work in the field is driven by a passion for reducing occupational hazards and ensuring the well-being of workers across various sectors.

Professional Profile 

Scopus

Orcid

Google Scholar

Suitability Summary for the Best Researcher Award

Kaan Koçali is a highly qualified candidate for the "Research for Best Researcher Award" due to his extensive academic background, notable research contributions, and impactful roles in various projects, particularly in the field of Occupational Health and Safety (OHS) and mining engineering. He has a diverse academic foundation, holding a doctorate in Occupational Health and Safety, along with multiple master's degrees in related fields. His dissertation work, including the development of a document tracking and control system for miners, demonstrates a commitment to addressing real-world problems with practical solutions. This focus on both legal frameworks and technological advancements in the mining industry is indicative of his innovative approach to research.

Kaan has been involved in several national and international projects, including leading research on safety measures and risk assessments in the mining sector, a crucial area for both worker safety and industry development. His significant involvement in various research projects, like the TÜBΔ°TAK-supported anthropometric data project and KOSGEB’s innovation programs, shows his leadership skills and capacity to drive research that can directly impact both industry standards and public safety.

Education

Dr. KoΓ§ali’s educational journey spans several disciplines, culminating in a doctoral degree in Occupational Health and Safety from Istanbul AydΔ±n University (2021). He completed his thesis on β€œLegal Obligations of Permanent Supervisors in Mines” under the guidance of Reşit ErΓ§etin. Prior to his doctorate, Dr. KoΓ§ali earned a master’s degree in Mining Engineering from Istanbul University (2016), focusing on the impact of boron compounds in solar panels. His academic foundation also includes an undergraduate degree in Mining Engineering, a master's in Occupational Health and Safety, and additional education in business and entrepreneurship. His academic qualifications underpin his research and teaching excellence, as he continuously strives to enhance workplace safety standards.

Professional Experience

Dr. Kaan KoΓ§ali’s professional experience spans academic teaching, research, and consultancy. He is currently a faculty member at Istanbul Gelisim University, teaching courses in Occupational Health and Safety. His involvement in national and international research projects has positioned him as a key figure in the mining and safety sectors. Dr. KoΓ§ali has contributed to various initiatives, such as projects focused on mining sector consultancy and safety regulations. He also collaborates with organizations like KOSGEB on innovation and research programs, improving safety systems in the mining industry. Through these roles, Dr. KoΓ§ali has helped shape policies and technologies aimed at reducing occupational risks and promoting safer work environments. His projects have earned recognition, contributing significantly to the field of workplace health and safety.

Awards and Recognition

Dr. Koçali has received several prestigious awards for his contributions to occupational health and safety. Notably, he was honored with the "Best Researcher Award" at the International Research Awards on Science, Health, and Engineering in 2023 and 2022. Additionally, he received the "Top Researcher Award" at the International Conference on Cybersecurity and Cryptography in 2023. Dr. Koçali's research on occupational health, safety, and mining engineering continues to garner global recognition for its practical applications and impact on workplace safety. His work on risk assessments and safety improvements has made him a sought-after expert in his field. These accolades affirm his dedication and excellence in improving safety standards and research in the occupational health sector.

Research Skills On Health Professions

Dr. KoΓ§ali is highly skilled in risk assessment, occupational health research, and mining safety systems. He has expertise in using advanced methods such as the TOPSIS method for selecting personal protective equipment and the Fine-Kinney risk assessment technique for underground mining operations. His research skills also extend to assessing the impact of daylight saving time on work accidents, as well as improving safety standards in industries like automotive and mining. Dr. KoΓ§ali’s proficiency in safety system analysis, regulatory assessments, and his ability to conduct extensive field research have contributed to his success in both academic and practical applications. He continues to lead significant projects aimed at improving safety regulations and creating safer workplaces across various industries.

Publication Top Notes

  • Title: Sosyal GΓΌvenlik Kurumu’nun 2012-2020 YΔ±llarΔ± ArasΔ± İş KazalarΔ± GΓΆstergelerinin Standardizasyonu
    Author: K. Koçali
    Citation: 44
    Year: 2021

  • Title: Calculation of Occupational Accident Indicators of TΓΌrkiye
    Author: K. Koçali
    Citation: 17
    Year: 2021

  • Title: AΓ§Δ±k Ocak Maden İşletmelerinde İşçi Anketleri ile İş Sağlığı ve GΓΌvenliği KΓΌltΓΌrΓΌ ve UygulamasΔ±nΔ±n AraştΔ±rΔ±lmasΔ±
    Author: K. Koçali
    Citation: 14
    Year: 2018

  • Title: Maden KazalarΔ±nda Sorumluluklar ve Kusur OranlarΔ±
    Author: K. Koçali
    Citation: 13
    Year: 2021

  • Title: Şırnak KΓΆmΓΌr Madeni KazasΔ± Işığında KΓΆmΓΌr Madenciliğindeki Uygunsuzluklar HakkΔ±nda Γ–neriler
    Author: K. Koçali
    Citation: 10
    Year: 2018

  • Title: How to Perform a Risk Assessment Step by Step for Occupational Health and Safety
    Author: K. Koçali
    Citation: 8
    Year: 2022

  • Title: Legal Regulations Regarding Liabilities of Workers and Employers Related to Occupational Health and Safety in Mining
    Authors: K. Koçali, R. Erçetin
    Citation: 7
    Year: 2021

  • Title: Madencilikte Proje Şirketlerinin Γ–nemi
    Author: K. Koçali
    Citation: 6
    Year: 2013

  • Title: 18-65 Yaş ArasΔ± Kişilerin Antropometrik Verilerinin Belirlenmesi Üzerine Bir Alan AraştΔ±rmasΔ±: YΓΌksekâğretim Kurumu UygulamasΔ±
    Authors: S. Γ‡alış, Γ‡. Γ‡alış, K. KoΓ§ali, B.Y. BΓΌyΓΌkakΔ±ncΔ±
    Citation: 5
    Year: 2021

  • Title: TΓΌrkiye’de 2017 YΔ±lΔ±nda Yaşanan KΓΆmΓΌr Madeni FaciasΔ± SonrasΔ± SektΓΆrΓΌn İş Sağlığı ve GΓΌvenliği AΓ§Δ±sΔ±ndan Δ°rdelenmesi
    Author: K. Koçali
    Citation: 5
    Year: 2019

PRAJAKTA MASURKAR | Health Professions | Best Researcher Award

Posted on by sciencefather

Dr. PRAJAKTA MASURKAR | Health Professions | Best Researcher Award

πŸ‘€ Dr. PRAJAKTA MASURKAR, UCB, United States

Prajakta P. Masurkar, Ph.D., MPharm, is a dynamic HEOR (Health Economics and Outcomes Research) professional specializing in evidence generation for payer-focused strategies in inflammatory and rare diseases. With over 7 years of experience in HEOR research and an additional 3 years in the pharmaceutical industry, Dr. Masurkar excels in retrospective data analysis, economic modeling, patient-reported outcomes strategies, and advanced research designs. Her expertise extends to clinical development, market access, and health technology assessments (HTAs). Currently serving as HEOR Associate Director at UCB, Atlanta, she leads impactful research initiatives, integrating US payer evidence with global strategies. A skilled communicator and strategic thinker, she has a proven ability to deliver research outcomes aligning with business development and policy objectives. Dr. Masurkar’s academic journey includes a Ph.D. in Pharmaceutical Health Outcomes and Policy, reflecting her dedication to advancing healthcare innovation and enhancing the patient experience through data-driven insights.

Professional Profile

Scopus 

Orcid

🌟  Summary of Suitability for the Award

Dr. Prajakta P. Masurkar is an exemplary candidate for the β€œResearch for Best Researcher Award.” With a profound blend of academic accomplishments, industry experience, and research expertise, Dr. Masurkar has significantly contributed to the fields of Health Economics and Outcomes Research (HEOR), pharmacoepidemiology, and pharmacoeconomics. Her seven years of HEOR research experience and additional three years in the pharmaceutical industry showcase her depth of knowledge and versatility in tackling complex challenges related to health economics, payer strategies, and clinical evidence generation.

Dr. Masurkar’s impactful work is evident in her leadership roles, including her current position as Associate Director at UCB and her tenure at Amgen, where she spearheaded numerous research initiatives. Her contributions span diverse therapeutic areas, including dermatology, inflammation, lupus, and rare diseases.

πŸŽ“ Education

Dr. Prajakta P. Masurkar holds a Ph.D. in Pharmaceutical Health Outcomes and Policy from the University of Houston, Texas, USA (2017–2021). Her doctoral research emphasized pharmacoepidemiology and pharmacoeconomics, honing her expertise in health outcomes research. She earned her Master of Pharmacy (MPharm) in Drug Development and Regulatory Affairs from Narsee Monjee Institute of Management Studies (NMIMS), Mumbai, India, with a focus on innovative analytical methods and regulatory frameworks. Dr. Masurkar’s academic journey began with a Bachelor of Pharmacy (BPharm) from the University of Mumbai, India, where she developed foundational knowledge in pharmaceutical sciences. Throughout her education, she maintained impressive GPAs, showcasing her academic rigor and commitment to excellence. Her multidisciplinary training equips her with the skills to navigate complex health economic evaluations, evidence generation, and global regulatory landscapes, enabling her to make meaningful contributions to the field of healthcare research and policy development.

πŸ’Ό  Professional Experience

Dr. Prajakta P. Masurkar’s professional journey spans over a decade of impactful roles in Health Economics and Outcomes Research (HEOR) and the pharmaceutical industry. As HEOR Associate Director at UCB, Atlanta, she leads evidence generation initiatives for dermatology, integrating global strategies with US payer requirements. At Amgen, she held senior and managerial positions, driving HEOR strategies for inflammation-related conditions, including lupus and atopic dermatitis. Her responsibilities encompassed economic modeling, real-world evidence studies, and HTA submissions. Earlier roles included a Global HEOR internship at Intuitive Surgical, where she developed cost-effectiveness analyses for robotic-assisted surgeries, and a Teaching Assistantship at the University of Houston. In India, she contributed to pharmacovigilance and regulatory affairs with leading pharmaceutical firms. Dr. Masurkar’s cross-functional collaborations, strategic leadership, and technical expertise underscore her commitment to advancing patient care and optimizing healthcare value propositions through evidence-based solutions.

πŸ… Awards and Recognition

Dr. Prajakta P. Masurkar has earned recognition for her exceptional contributions to health economics and outcomes research. Her achievements include impactful presentations at esteemed conferences such as the American College of Rheumatology (ACR) Annual International Meeting, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and the Academy of Managed Care Pharmacy (AMCP). Notable podium and poster presentations highlight her groundbreaking work on treatment patterns, healthcare resource utilization, and cost analyses in systemic lupus erythematosus. Her expertise in economic modeling and patient-reported outcomes strategies has been acknowledged with invitations to present globally. Additionally, her dedication to advancing health outcomes research has been celebrated with opportunities to mentor and collaborate with global experts. These recognitions reflect Dr. Masurkar’s unwavering commitment to excellence and her influential role in shaping innovative solutions for complex healthcare challenges.

🌍 Research Skills On Health Professions

Dr. Prajakta P. Masurkar possesses a diverse and advanced skill set in health economics and outcomes research. Her expertise includes economic modeling, health technology assessments (HTA), and patient-reported outcomes (PRO) strategies, tailored to improve healthcare access and optimize payer value propositions. She is adept in retrospective claims analysis, real-world evidence (RWE) studies, and systematic reviews, leveraging extensive experience with databases like MarketScan, Medicare, and EMR systems. Proficient in programming tools like R, Python, and SAS, Dr. Masurkar applies quantitative and qualitative methods to generate impactful evidence. She excels in decision-analytic modeling and cost-effectiveness analyses, enhancing decision-making for stakeholders. Her technical acumen extends to scientific writing, including Global Value Dossiers (GVD) and HTA submissions, ensuring compliance and effectiveness. With an innovative approach and a commitment to precision, Dr. Masurkar’s research skills empower her to deliver solutions addressing critical gaps in healthcare.

πŸ“– Publication Top Notes

1. Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study
  • Authors: Prajakta P. Masurkar, Satabdi Chatterjee, Jeffrey T. Sherer, Hua Chen, Michael L. Johnson, Rajender R. Aparasu
  • Citation: Drugs & Aging, DOI: 10.1007/s40266-022-00944-z
  • Year: 2022
2. Risk of Overactive Bladder Associated With Cholinesterase Inhibitors in Dementia
  • Authors: Prajakta P. Masurkar, Satabdi Chatterjee, Jeffrey T. Sherer, Hua Chen, Michael L. Johnson, Rajender R. Aparasu
  • Citation: Journal of the American Geriatrics Society, DOI: 10.1111/jgs.17579
  • Year: 2022
3. Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia
  • Authors: Prajakta P. Masurkar, Satabdi Chatterjee, Jeffrey T. Sherer, Rajender R. Aparasu
  • Citation: Drugs & Aging, DOI: 10.1007/s40266-021-00863-5
  • Year: 2021
4. A Naturalistic Observation Study of Medication Counseling Practices at Retail Chain Pharmacies
  • Authors: Soham D. Yande, Prajakta P. Masurkar, Suma Gopinathan, Sujit Sansgiry
  • Citation: Pharmacy Practice, DOI: 10.18549/PharmPract.2020.1.1696
  • Year: 2020
5. A Need of Better Pharmacovigilance System in India
  • Authors: Prajakta P. Masurkar
  • Citation: Asian Journal of Pharmaceutical and Clinical Research, DOI: 10.22159/ajpcr.2017.v10i1.14797
  • Year: 2017